Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia

被引：5
|
作者：
Hallner, Alexander [1 ]
Aurelius, Johan [1 ]
Thoren, Fredrik Bergh [1 ]
Sander, Frida Ewald [1 ]
Brune, Mats [1 ]
Hellstrand, Kristoffer [1 ]
Martner, Anna [1 ]
机构：
[1] Univ Gothenburg, Sahlgrenska Canc Ctr, S-40530 Gothenburg, Sweden
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2015年 / 94卷 / 03期
关键词：
D O I：
10.1111/ejh.12454
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：279 / 280
页数：2
相关论文
共 50 条
  • [21] IMMUNOTHERAPY OF MICE WITH A LARGE BURDEN OF DISSEMINATED LYMPHOMA WITH LOW-DOSE INTERLEUKIN-2
    MAAS, RA
    DULLENS, HFJ
    DEJONG, WH
    DENOTTER, W
    [J]. CANCER RESEARCH, 1989, 49 (24) : 7037 - 7040
  • [22] Immunotherapy with low-dose interleukin-2 and a polysaccharopeptide from Cariolus versicolor.
    Mao, XW
    Archambeau, JO
    Gridley, DS
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 175 - 175
  • [23] Posttreatment Interleukin-2 in Patients With Acute Myeloid Leukemia
    Grosso, Dolores
    Weiss, Mark A.
    [J]. CANCER, 2014, 120 (07) : 940 - 941
  • [24] LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTERLEUKIN-2 FOR MALIGNANT-MELANOMA
    MITCHELL, MS
    KEMPF, RA
    HAREL, W
    SHAU, H
    BOSWELL, WD
    LIND, S
    DEAN, G
    MOORE, J
    BRADLEY, EC
    [J]. BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1989, 65 (01) : 128 - 144
  • [25] Pharmacokinetics of histamine dihydrochloride in healthy volunteers and cancer patients: Implications for combined immunotherapy with interleukin-2
    Middleton, M
    Sarno, M
    Agarwala, SS
    Glaspy, J
    Laurent, A
    McMasters, K
    Naredi, P
    O'Day, S
    Whitman, E
    Danson, S
    Cosford, R
    Gehlsen, K
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (07): : 774 - 781
  • [26] Immunotherapy with low-dose interleukin-2 and interferon-gamma in a murine tumor model
    Mao, XW
    Kettering, JD
    Gridley, DS
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (12): : 1017 - 1027
  • [27] Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720
    Baer, Maria R.
    George, Stephen L.
    Caligiuri, Michael A.
    Sanford, Ben L.
    Bothun, Sandra M.
    Mrozek, Krzysztof
    Kolitz, Jonathan E.
    Powell, Bayard L.
    Moore, Joseph O.
    Stone, Richard M.
    Anastasi, John
    Bloomfield, Clara D.
    Larson, Richard A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4934 - 4939
  • [28] LOW-DOSE INTERFERON GAMMA RENDERS NEUROBLASTOMA MORE SUSCEPTIBLE TO INTERLEUKIN-2 IMMUNOTHERAPY
    SIGAL, RK
    LIEBERMAN, MD
    REYNOLDS, JV
    SHOU, J
    ZIEGLER, MM
    DALY, JM
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1991, 26 (04) : 389 - 396
  • [29] LOW-DOSE CYTARABINE IN ACUTE MYELOID-LEUKEMIA
    MANOHARAN, A
    LEYDEN, MJ
    SULLIVAN, J
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1984, 141 (10) : 643 - 646
  • [30] High-dose interleukin-2 may not be superior to low-dose interleukin-2 plus interferon
    Alikhan, M
    Spencer, HJ
    Kohli, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6267 - 6268
12345